Hold PM: retain dividend income stream, await technical confirmation before phased capital deployment
HOLD is the correct calibration: business quality is elite (40% operating margins, $9.7B TTM FCF, 3.16% dividend yield with 17-year increase streak), prior decision lessons confirm high-quality consumer staples consolidate rather than capitulate on technical signals, and technical deterioration is real but not structurally broken. The Neutral analyst's phased deployment framework with stop at $175.95 (~2 ATRs from $184 entry) mechanically captures upside if smoke-free thesis resumes while defining clear invalidation if medium-term uptrend breaks.
| Position | Action |
|---|---|
| First tranche: confirmed base above 50 SMA ($183.95) with MACD histogram flattening | Deploy initial position |
| Second tranche: retest of 20 SMA ($190.92) | Add to position |
| Final tranche: deeper flush to $175-180 OR confirmed breakout above $200 | Reserve final deployment |
| Daily close below $175.95 on volume >5M shares OR Brazil adverse ruling >$2B | Trim/exit position |
PM is a best-in-class defensive compounder trading near key technical support, with exceptional cash generation ($9.7B annual FCF), a 3.16% dividend yield with 10+ years of growth, low 0.4 beta, and an actively de-risking smoke-free transition that is already expanding margins and offsetting combustible tobacco secular decline.
| Indicator | Value | Signal |
|---|---|---|
| Price | $186.19 | neutral |
| 10 EMA | $188.24 | bearish |
| 50 SMA | $183.95 | bullish |
| 200 SMA | $169.03 | bullish |
| RSI (14) | 47.66 | neutral |
| MACD | 0.66 | bearish |
| MACD Signal | 1.82 | bearish |
| MACD Histogram | -1.16 | bearish |
| Bollinger Middle (20 SMA) | $190.92 | neutral |
| Bollinger Upper | $198.99 | bearish |
| Bollinger Lower | $182.85 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Retest of 20 SMA ($190.92)
Then: BUY second tranche
Brazil litigation is reserved, priced in, and represents a recurring pattern that fully reverses within 4-8 weeks
EV: +10-12% · concedes: Bear correctly identifies the -6.6% Brazil-related pullback as a real risk requiring monitoring; Bear is right that P/E of 25.6 and PEG of 2.42 represent a premium valuation that requires continued execution; Bear appropriately flags negative shareholder equity as an unconventional capital structure that warrants understanding
PM is fully priced at 90th+ percentile valuation with bearish technical momentum, structural risks from Brazil litigation and competitive intensity in ZYN, and fragile capital structure ($43.11B net debt, negative equity) that makes it vulnerable to multiple compression in a higher-for-longer rate environment — the timing and price are wrong for new entries.
· concedes: PM is a quality company with strong fundamentals including $9.7B FCF and 40% operating margins; Q2 2026 was strong in isolation; Working capital improvement from -$4.78B to -$0.54B is a positive development (though one-time); If PM can hold $183 and reclaim $190, the bullish structure remains intact
→ vs conservative: P/E of 25.58 and PEG of 2.42 are misread; forward P/E is 20.31 with 26% earnings growth consensus, and $35.5B treasury stock reflects capital return program, not credit concern at 2.4x Net Debt/EBITDA
→ vs conservative: Brazil litigation is a known and reserved-for structural overhang that has existed for decades; -6.6% reaction over 7 days against +9.6% over 90 days is textbook overreaction
→ vs conservative: Macro backdrop of 86% no Fed cuts probability and 8% recession risk actually supports high-quality high-yielding consumer defensives like PM; 3.16% yield plus 26% earnings growth beats 5% Treasuries
→ vs conservative: Negative book value from $35.5B treasury stock is a capital return feature, not a red flag; Net Debt to EBITDA of 2.4x is investment-grade
→ vs neutral: Price $4.73 below 20 SMA at $190.92 represents accumulation zone within intact uptrend, not bearish momentum pattern; 50 SMA test at $183.95 is confluence support, not breakdown
→ vs neutral: ZYN capacity expansion framing as 'structural positive to monitor' completely misses that $1.2B Aurora campus commitment locks in multi-year volume growth and underwrites smoke-free transition thesis
→ vs neutral: Asymmetric risk/reward math is flawed; waiting for technical confirmation means missing 2.5% bounce from $186 to $190.92 and potential $190 to $195 re-test; cost of waiting exceeds $10 lower entry benefit
| bullish |
| ATR (14) | $4.95 | neutral |
Support: 182.85 · 183.95 · 175.95 · 169.03 | Resistance: 190.92 · 194.3 · 198.99 · 200.17
HOLD with bullish bias. The long-term structural uptrend remains intact (price +10.1% above rising 200 SMA, 50 SMA above 200 SMA by $14.92), but short-term momentum is bearish with MACD in bearish crossover and 10 EMA above price. Critical support confluence at $182.85–$183.95 should be monitored for accumulation opportunity; a close below $182.85 on elevated volume would signal deeper correction risk toward $175.95.
Market Cap
$290.2B
Beta
0.4
Dividend Yield
3.16%
P/E (TTM)
25.58
Forward P/E
20.31
PEG Ratio
2.42
P/B
-33.81
52-Week High
$207.76
52-Week Low
$142.11
50-Day Avg
$184.15
200-Day Avg
$171.05
EPS (TTM)
$7.28
Forward EPS
$9.17
Net Revenue (2025)
$40,648M
Operating Revenue (2025)
$93,859M
Gross Profit (2025)
$27,282M
Gross Margin
67.1%
Operating Income (2025)
$14,933M
Operating Margin
40.0%
EBITDA (2025)
$17,463M
Net Income (2025)
$11,316M
Diluted EPS (2025)
$7.26
Profit Margin
25.6%
ROA
14.6%
TTM Revenue
$42.55B
TTM Gross Profit
$28.71B
TTM EBITDA
$18.02B
TTM Net Income
$10.84B
TTM Operating CF
$12.2B
TTM Free Cash Flow
$9.71B
FCF Margin
22.8%
CapEx (2025)
$1,569M
Cash Dividends Paid (2025)
$8.62B
TTM Dividends Paid
$9.0B
Total Assets
$68.27B
Cash & Equivalents
$6.00B
Short-Term Debt
$6.75B
Long-Term Debt
$42.37B
Total Debt
$49.11B
Net Debt
$43.11B
Net Debt / EBITDA
2.4x
Current Ratio
0.98
Treasury Stock
$35.46B
Stockholders Equity
-$8.58B
Goodwill (Swedish Match)
$17.3B
Q2 2026 Revenue
$11.19B
Q2 2026 Operating Income
$4.53B
Q2 2026 Net Income
$2.82B
Q2 2026 Diluted EPS
$1.80
Q2 2026 EBITDA
$5,048M
Q2 2026 FCF
$5,112M
H1 2026 Revenue
$21.34B
Working Capital (Q2 2026)
-$0.54B
Strengths
Concerns
Philip Morris International exhibits elite fundamental characteristics with 40% operating margin, 25%+ net margin, and $9.7B TTM free cash flow, supported by a 3.16% dividend yield and low-beta (0.4) defensive profile. Q2 2026 showed strong acceleration with $11.19B revenue (+10.4% YoY) and record EBITDA of $5.05B, while net debt declined $4.2B YoY to $43.1B. However, premium valuation (P/E 25.6, PEG 2.42) combined with negative book value and structural headwinds (regulatory, FX, secular cigarette decline) limits the risk/reward at current levels, supporting a HOLD recommendation for existing shareholders while awaiting a pullback toward the 200-day moving average (~$171) for new entries.
Macro: Fed policy: Polymarket 86% probability of no cuts in 2026 (down 2.5pp WoW, $7.2M volume). Recession risk: 8% U.S. by end-2026 (down 1pp WoW, $1.7M volume); UK 20% (up 5.5pp); Japan 28% (down 4.5pp). Inflation: >5% in 2026 at 10% (down 2.5pp); >4.5% at 20%; >6% at 3%; >10% at 3%. Equities: Nasdaq led on AI earnings and benign CPI; broad market mixed. Yields drifting lower on lower-than-prior inflation prints.